E88.3 - Tumor lysis syndrome

Applicable to Tumor lysis syndrome
The 2025 edition of ICD10-CM E88.3 became effective on October 1, 2024.
This is the American ICD10-CM version of E88.3 - other international versions of ICD10 E88.3 may differ.
E88.3 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

Code Additional Code

code for adverse effect, if applicable, to identify drug (T45.1X5)

Inclusion Term

Tumor lysis syndrome (spontaneous)
Tumor lysis syndrome following antineoplastic drug chemotherapy

The following codes above E88.3 contain annotation back-references that may be applicable to E88.3:

Chapter: E00-E89 Endocrine, nutritional and metabolic diseases

Section: E70-E88 Metabolic disorders

Category: E88 Other and unspecified metabolic disorders

syndrome icd 10

Billable/Specific Code

Browse other similar CM codes

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Please, give attribution to our website icd-10code.com